Oscar Sotolongo-Grau

Citado por

	Total	Desde 2020
Citas	4292	3578
Índice h	23	20
Índice i10	36	29

1200

600

300

900

20142015201620172018201920202021202220232024202515 33 51 92 226 230 269 399 575 863 1183 273

Acceso público

Ver todo

47 artículos

1 artículo

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Mercè Boada, MD, PhDNeuróloga. MD, PhDDirección de correo verificada de fundacioace.com
Agustin Ruiz LazaGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases. UTHSCSA, San Antonio, TexasDirección de correo verificada de uthscsa.edu
Montse AlegretJefe de la Unidad de Neuropsicología. Funació ACEDirección de correo verificada de fundacioace.org
Sergi ValeroAce Alzheimer Center BarcelonaDirección de correo verificada de fundacioace.org
Angela SanabriaDirección de correo verificada de econsulta.isalus.es
Daniel Rodríguez-PérezDeptartamento de Física Matemática y de Fluidos (UNED)Dirección de correo verificada de dfmf.uned.es
José Carlos AntoranzProfesor de Física (UNED)Dirección de correo verificada de dfmf.uned.es
Marta Marquié, MD, PhDAce Alzheimer Center BarcelonaDirección de correo verificada de fundacioace.com
Alba Pérez-CordónFundació ACEDirección de correo verificada de fundacioace.org
Virginia Pérez-GrijalbaInvestigadora Biología MolecularDirección de correo verificada de certest.es
Núria RoéCentro de Investigaciones Médico-Sanitarias, Fundación General de la Universidad de MálagaDirección de correo verificada de fguma.es
James T. Becker, Ph.D.Emeritus Professor of Psychiatry, Neurology and PsychologyDirección de correo verificada de pitt.edu
Itziar de RojasLuxembourg Centre for Systems Biomedicine (LCSB)Dirección de correo verificada de fundacioace.org
Sonia Moreno-GrauStanford University, School of MedicineDirección de correo verificada de stanford.edu
Javier ArbizuNuclear Medicine. Clínica Universidad de NavarraDirección de correo verificada de unav.es
Pablo Martinez-LageCITA alzheimer FoundationDirección de correo verificada de cita-alzheimer.org
Alfredo Ramirez, MD, PhDUniversity of Bonn and University of CologneDirección de correo verificada de uk-koeln.de
Susan LandauUniversity of California, BerkeleyDirección de correo verificada de berkeley.edu
Luis GaggeroDirector, Facultad de Ciencias, UAEMDirección de correo verificada de uaem.mx
Maria Victoria FernandezFundacio ACE Institut de Neurosciencies AplicadesDirección de correo verificada de fundacioace.org

Seguir

Oscar Sotolongo-Grau

ACE Alzheimer Center Barcelona, Barcelona, Spain

Dirección de correo verificada de fundacioace.org - Página principal

Complex Systems Statistical Mechanics Medical Physics Neuroimaging HPC


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022	1588	2022
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373, 2017	1013	2017
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021	255	2021
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019	161	2019
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, ... Molecular psychiatry 22 (1), 153-160, 2017	120	2017
Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, ... Translational psychiatry 4 (2), e358-e358, 2014	115	2014
New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020	75	2020
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study V Pérez-Grijalba, J Arbizu, J Romero, E Prieto, P Pesini, L Sarasa, ... Alzheimer's research & therapy 11, 1-9, 2019	55	2019
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's Research & Therapy 10, 1-12, 2018	51	2018
The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline A Sanabria, M Alegret, O Rodriguez-Gomez, S Valero, O Sotolongo-Grau, ... Scientific Reports 8 (1), 3828, 2018	49	2018
Early detection of amyloid load using ¹⁸F-florbetaben PET S Bullich, N Roé-Vellvé, M Marquié, SM Landau, H Barthel, ... Alzheimer's research & therapy 13, 1-15, 2021	48	2021
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy … S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ... Alzheimer's & Dementia 14 (5), 634-643, 2018	48*	2018
Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer’s disease individuals: replication of diastolic blood pressure correlations and analysis of … A Ruiz, P Pesini, A Espinosa, V Pérez-Grijalba, S Valero, ... PLoS One 8 (11), e81334, 2013	48	2013
Retinal microperimetry: a new tool for identifying patients with type 2 diabetes at risk for developing Alzheimer disease A Ciudin, O Simó-Servat, C Hernández, G Arcos, S Diego, Á Sanabria, ... Diabetes 66 (12), 3098-3104, 2017	47	2017
FACEHBI: A prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols O Rodriguez-Gomez, A Sanabria, A Perez-Cordon, D Sanchez-Ruiz, ... J Prev Alzheimers Dis 4 (2), 100-108, 2017	43	2017
Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment M Alegret, G Cuberas-Borrós, A Espinosa, S Valero, I Hernández, A Ruíz, ... Journal of Alzheimer’s Disease 41 (3), 739-748, 2014	41	2014
Tissue radiation response with maximum Tsallis entropy O Sotolongo-Grau, D Rodriguez-Perez, JC Antoranz, O Sotolongo-Costa Physical review letters 105 (15), 158105, 2010	41	2010
Assessment of cancer immunotherapy outcome in terms of the immune response time features D Rodriguez-Perez, O Sotolongo-Grau, RE Riquelme, O Sotolongo-Costa, ... Mathematical medicine and biology: a journal of the IMA 24 (3), 287-300, 2007	40	2007
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study P Bosco, A Redolfi, M Bocchetta, C Ferrari, A Mega, S Galluzzi, M Austin, ... Alzheimer's & Dementia 13 (9), 1013-1023, 2017	39	2017
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ... Alzheimer's research & therapy 12, 1-14, 2020	38	2020

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores